Advanced breast cancer: recent developments in hormonal therapy.
OBJECTIVE
To review recent developments in hormonal therapy for metastatic breast cancer.


METHODS
Published books and articles.


CONCLUSIONS
Newer hormonal agents are offering women alternatives for sequential therapy of metastatic disease that provide benefit with less risk.


CONCLUSIONS
A thorough understanding of the relationship between hormonal influences and breast cancer will assist nurses to better appreciate the variety of agents now available and their specific indications, outcomes, and effects. Common side effects include weight gain, hot flashes, nausea, and skin and vaginal changes. Nursing efforts focus on the areas of body image disturbance, side effect management, and fostering healthy relationships.
Cloutier
A O
AO
Shering Oncology Biotech, Kenilworth, NJ, USA.
D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D020847:Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009723:Nurse-Patient Relations; D009859:Oncology Nursing; D011379:Prognosis
D047072:Aromatase Inhibitors; D020847:Estrogen Receptor Modulators